Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Onco…

Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct ...